Referencias • The Omega 3 Connection. Andrew Stoll MD. (libro) Simon & Schuster, 2001 • Gesch, B, Hammond S, Hampson S et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Brit J Psychiatry 2002 July; 181: 22–8. • Martínez-González MA et al. Ácidos grasos omega-3 de pescado y riesgo de enfermedad coronaria. Med Clin (2003) Vol. 121. Núm. 01 • Baghai et al. Major Depressive Disorder is associated with cardiovascualr risk factor4s and low omega-3 index. 2010. Journal of Clinical Psychiatry • Drobnic F. et al. Krill Oil- dependent increases in HS Index – Omega3- Index, plasma choline and antioxidant in well conditioned training power athletes. Nutrients. 2021 Nov 25;13(12):4237. • García JC et al. Acidos grasos omega 3 y depresión. Una revisión sistemática. Psiquiatría biológica 2017. 24(1), 10-17 • McBurney et al. Using an erythrocyte fatty acid fingerprint to predict risk of all-cause mortality: the Framingham Offspring Cohort. Am J Clin Nutr 2021; Jun 16:nqab165 • Von Schacky, Clemens. Importance of EPA and DHA Blood Levels in Brain Structure and Function. Nutrients 2021, 13, 1074. https://doi.org/10.3390/nu13041074 • Lopresti AL, et al. Efficacy of a standardised Saffron Extract (affron®) as an add-on to Antidepressant Medication for treatment of Persistent Low Mood an Frustration Syntoms in Adults. J of Affective Disorders. 2017 Jan 1; 207:188-196 • Lopresti AL, et al. The effect of a standardised Saffron Extract (affron®) on Menopausal Symtoms in Women during Perimenopause. J of Menopausal Medicine. 2021; 27:1-13
RkJQdWJsaXNoZXIy MTQzMjMwMg==